Sakk 38/19: Assessing a CTDNA and Pet-Oriented Therapy in Patients with DLBCL. A Multicenter, Open-Label, Phase II Trial.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_673A6612EFD7
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
UNIL/CHUV
Title
Sakk 38/19: Assessing a CTDNA and Pet-Oriented Therapy in Patients with DLBCL. A Multicenter, Open-Label, Phase II Trial.
Title of the conference
Hematological oncology
Author(s)
Stathis A., Hitz F., Schär S., Novak U., Fischer N., Mey U., Gritti G., Zander T., Lang N., Cairoli A., Zenz T., Rhyner G., Mingrone W., Schmidt A., Gaidano G., Hohaus S., Stern A.O., Mamot C., Bruscagin A., Musilova J., Hayoz S., Bertoni F., Zucca E., Dirnhofer S., Ceriani L., Rossi D.
Organization
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, 13 ‐ 17 June, 2023
Address
Lugano, Switzerland
ISSN
1099-1069 (Electronic)
ISSN-L
0278-0232
Publication state
Published
Issued date
06/2023
Peer-reviewed
Oui
Volume
41
Number
Suppl 2
Pages
165-166
Language
english
Keywords
Humans, Lymphoma/therapy, Switzerland, Congresses as Topic
OAI-PMH
oai:serval.unil.ch:BIB_673A6612EFD7
DOI
10.1002/hon.3163_T01
Pubmed
39112407
Open Access
Yes
Create date
09/08/2024 14:44
Last modification date
10/08/2024 6:30
Usage data